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ABSTRACT 12 
 13 
Purpose: To assess the effect of autosomal dominant optic atrophy (ADOA) on ON 14 
and OFF retinal ganglion cell (RGC) function by evaluating the ON and OFF 15 
components of the photopic negative response (PhNR). 16 
 17 
Methods: Twelve participants from 6 families with OPA1 ADOA and 16 age matched 18 
controls were recruited. Electrophysiological assessment involved pattern 19 
electroretinograms (PERG), focal (20o) and full-field long duration (250msec) flash 20 
ERGs using a red light emitting diode flash on a rod saturating blue background, and 21 
full-field brief (300 µsec) xenon flash ERGs using a red filter over a continuous rod 22 
saturating blue background. Amplitudes and implicit times of the ERG components 23 
were analyzed and the diagnostic potential of each electrophysiological technique 24 
was determined by generating receiver operating characteristic (ROC) curves. 25 
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 26 
Results: Mean amplitudes of the N95 and all PhNRs, except the full-field PhNRON, 27 
were significantly reduced in participants with ADOA (p<0.01). Subtraction of the 28 
group averaged focal ERG of ADOA participants from that of controls showed an 29 
equal loss in the focal PhNRON and PhNROFF components, while in the full-field ERG 30 
the loss in the PhNROFF was greater than that in the PhNRON component. The Areas 31 
Under the ROC Curve (AUC) for the focal PhNRON (0.92), focal PhNROFF (0.95) and 32 
full-field PhNROFF (0.83), were not significantly different from that of the PERG N95 33 
(0.99). 34 
 35 
Conclusions: In patients with ADOA, the PhNRON and PhNROFF components are 36 
nearly symmetrically reduced in the long duration ERG suggesting that ON- and 37 
OFF-RGC pathways may be equally affected.  38 
 3 Accepted 21-10-2015 
 
Introduction 39 
Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy 40 
characterized by variable bilateral loss of vision in early childhood, optic nerve pallor, 41 
centrocoecal visual field scotoma and color vision defects 2-6. It is the commonest 42 
hereditary optic neuropathy with a prevalence between 1 in 50,000 to 1 in 8,000 7-12.  43 
 44 
ADOA is caused primarily by mutations in the autosomal nuclear gene, OPA1 10, 13-45 
16, a key player in mitochondrial dynamics, controlling mitochondrial fusion, amongst 46 
other key roles. Histopathological studies in humans 17, 18 and mouse models 19-22 47 
show that ADOA is principally characterized by the degeneration of the retinal 48 
ganglion cells (RGC). 49 
 50 
In a mouse model of ADOA, generated in our laboratory 22, the defect is first evident 51 
as a dendritic pruning of RGCs in B6:C3-Opa1Q285STOP Opa1 mutant mouse which 52 
appears to be ON-center specific19, 23. This selective vulnerability of ON-center 53 
RGCs may reflect their higher energy demands in comparison to their OFF-center 54 
counterparts, since OPA1 mutations are thought to curtail mitochondrial energy 55 
output19, 23. This new finding has however not been investigated in humans with 56 
ADOA. 57 
 58 
The functional integrity of RGCs can be evaluated by assessing the photopic 59 
negative response (PhNR) of the flash ERG. The PhNR is a negative potential seen 60 
after the b-wave in a photopic ERG elicited by a brief flash. The PhNR is believed to 61 
primarily originate from spiking activity in RGCs and their axons with contributions 62 
from amacrine cells and possible involvement of associated glial cells/astrocytes of 63 
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the retina 24-27. When a long duration flash is used to evoke the ERG, the PhNR is 64 
seen once after the b-wave (PhNRON) and again as a negative going potential after 65 
the d-wave (PhNROFF). Furthermore, it has been demonstrated that the ERG 66 
obtained in response to a long duration red flash of moderate intensity provides 67 
optimal delineation of the PHNRON and PhNROFF components24, 27, 28. 68 
 69 
The brief flash PhNR is attenuated in patients with ADOA 29 and in the Opa1Q285STOP 70 
mutant mouse30. In the mouse model, the defect is seen prior to any changes in 71 
visual acuity on optokinetic drum testing and prior to morphological changes on 72 
retinal histology. This suggests that retinal connectivity may be affected before RGC 73 
somal loss impacts on RGC function23. Thus the PhNR deficit could serve as a 74 
marker for early disease. These early changes in RGC function may be reversible 75 
and need to be defined as markers for targeted therapies in any forthcoming 76 
therapeutic trials. 77 
 78 
Miyata et al (2007) and Barnard et al (2011) highlight the diagnostic potential of the 79 
PhNR in ADOA, however, the investigators used a brief white flash (broadband 80 
stimulus) to evoke the PhNR, which provides a poor signal to noise ratio compared 81 
to monochromatic stimuli27, and cannot distinguish ON and OFF components. 82 
Furthermore, the studies elicited full-field (global) PhNRs which, in contrast to the 83 
focal PhNR, are less sensitive in detecting focal retinal lesions such as those seen in 84 
early to moderate glaucoma 31, 32. As ADOA results in localized centrocoecal visual 85 
field defects2, it might be expected that a focal stimulus presented to this region 86 
would enhance the sensitivity of the PhNR to early disease-related changes. 87 
 88 
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The aim of this study was to assess the relative effect of ADOA on the PhNRON and 89 
PhNROFF components elicited using focal and full-field long duration red flashes on a 90 
rod suppressing blue background. An additional aim was to compare the diagnostic 91 
potential of the long duration PhNRs to responses which have previously been 92 
shown to be affected by ADOA; the full-field brief flash PhNR 29, 30 and the N95 93 
amplitude of the pattern electroretinogram (PERG) 33, which also reflects spiking 94 
activity of the RGCs 34.  95 
 96 
 97 
Methods 98 
Participants 99 
Twelve participants (aged 18 – 61 years) from six families with documented OPA1 100 
mutations and 16 healthy age matched controls (aged 19 – 61 years) were recruited 101 
for the study (see Table 1 for characteristics of all 12 participants). Detailed 102 
information about the clinical characteristics of nine of the participants have been 103 
reported elsewhere2. The study conformed to the Declaration of Helsinki and was 104 
approved by the National Health Service Research Ethics Committee for Wales as 105 
well as the ethics committees of the School of Optometry and Vision Sciences, 106 
Cardiff University, and the Division of Optometry and Visual Science, City University, 107 
London. All participants provided their written consent after receiving a participant 108 
information sheet and having the opportunity to ask questions. Nine participants with 109 
ADOA (ID numbers 1010-1017, 1021) were examined in Cardiff and the rest at City 110 
University London by the same investigator. 111 
 112 
Electroretinograms  113 
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All ERGs were recorded monocularly using a DTL fiber active electrode (Unimed 114 
Electrode Supplies, Ltd, Surrey, UK) and a contralateral reference. The DTL fiber 115 
was placed in the lower fornix to maximize stability during recording and the loose 116 
end fastened using medical tape at the inner canthus (Blenderm, Viasys Healthcare 117 
Ltd., Warwick, UK). A silver-silver chloride 10mm diameter touch-proof skin electrode 118 
(Unimed Electrode Supplies, Ltd, Surrey, UK), placed at the mid-frontal forehead 119 
position was used as ground electrode.  120 
 121 
ERG responses were obtained using an evoked potential monitoring system 122 
(Medelec EP, Oxford Instruments PLC, Surrey, UK [Cardiff site]; Espion, Diagnosys 123 
LLC, Cambridge, UK [City University site]). Responses were bandpass filtered from 124 
1 – 100 Hz and digitally averaged. Signals were recorded in blocks of 10 - 20 125 
responses, with a total of 40 – 60 averaged per trace. Between 4 and 6 traces were 126 
obtained for each stimulus condition. The traces were superimposed to confirm 127 
signal repeatability and averaged off-line into a single averaged trace containing 160 128 
– 300 responses. An automatic artefact rejection system removed signals 129 
contaminated by large eye movements and blinks.  130 
 131 
Transient PERG stimuli (4 reversals per second; check size = 1o) were generated on 132 
a computer monitor at 98% contrast. The screen was masked with a black opaque 133 
cardboard with a 13 x 13 cm square cut-out at the center so that it produced a 20o x 134 
20o field at a viewing distance of 36cm. 135 
 136 
Long duration ERGs were recorded using a red flash stimulus (peak output 660nm, 137 
250msec duration, 3.33 log phot td, 2Hz) on a rod saturating blue background (peak 138 
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output 469nm, 3.49 scot log td) produced by a hand-held miniature Ganzfeld light 139 
emitting diode (LED) stimulator (CH Electronics, Kent, UK).  Focal stimulation was 140 
produced by mounting the miniature Ganzfeld LED tube into the middle of a light box 141 
(44 cm x 44 cm x 10 cm) such that the circular stimulus subtended 20o diameter at a 142 
viewing distance of 15.6 cm. The 20o stimulus size was chosen to encompass as 143 
much of the central field as possible while avoiding the optic disc which starts about 144 
12o-15o nasal to the fovea. In order to minimize the effect of stray light stimulating the 145 
peripheral retina (i.e. the area outside the stimulus area) the light box contained a 146 
strip of white LEDs (Super Bright InGan) passed through a blue filter (Lee Filter 068 147 
Sky Blue, Lee Filters, Hampshire, UK) to produce a desensitizing blue surround of 148 
3.73 scot log td (field size = 109o x 109o field). Cross hairs centered in the middle of 149 
the stimulus served as the fixation target. Full-field ERGs were recorded by holding 150 
the stimulator head, fitted with a diffusing cap, directly to the eye. 151 
 152 
Full-field brief (flash) ERGs were elicited by a Ganzfeld stimulator (GS2000, LACE 153 
Elettronica, Italy) presenting a xenon flash stimulus (1.76 log td.s, 300 µsec 154 
maximum flash duration, 4Hz). Filters were used to obtain a red stimulus (Lee Filter 155 
“Terry Red”, Lee Filters, Hampshire, UK, transmittance <5% at wavelengths shorter 156 
than 575 nm, and above 85% from 625–700 nm) over a continuous rod saturating 157 
3.39 scot log td blue background (Schott Glass filter BG28, Schott AG, Mainz, 158 
Germany, peak transmittance 454 nm). All stimulus backgrounds were of sufficient 159 
scotopic illuminance to saturate the rods35. 160 
 161 
All ERGs were recorded by the same investigator using the same protocol at both 162 
sites. Long duration ERGs (focal and full-field) were generated by the same 163 
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miniature Ganzfeld LED stimulator at both sites. PERG and full-field brief flash data 164 
were only obtained from participants attending Cardiff University, in order to ensure 165 
consistency. All stimuli were calibrated using an ILT 1700 radiometer with 166 
SED033/Y/R luminance detector (Able Instruments and Controls, Reading, UK) 167 
assuming a 7 mm pupil with no correction for the Stiles-Crawford effect. The 168 
wavelength of the light sources were measured using a Specbos 1201 spectro-169 
radiometer (Horiba Jobin Yvon Ltd, Middlesex, UK). 170 
 171 
Procedures 172 
All participants underwent a comprehensive ophthalmic examination which included 173 
best corrected visual acuity (ETDRS), contrast sensitivity (Pelli-Robson), visual field 174 
assessment (24-2 SITA-FAST, Humphrey Visual Field Analyzer), slit lamp 175 
biomicroscopy, optical coherence tomography (OCT; Topcon 3D-OCT 1000), fundus 176 
photography, color vision (D-15 desaturated test) and auto-refraction. In order to 177 
target earlier stage ADOA, the eye with the better visual field mean deviation score 178 
was selected for ERG recording, with the dominant eye chosen in the case of equal 179 
scores between the two eyes.  180 
 181 
PERGs were always recorded first with natural pupils and near refractive correction 182 
when necessary. Pupils were then dilated using 1% tropicamide to a minimum of 183 
7mm and flash ERGs were recorded in the following order: focal long-duration, full-184 
field long duration and full-field brief flash ERG.  185 
 186 
Signal Analysis 187 
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PERGs and focal ERGs were Fourier analyzed to remove high frequency noise 188 
above 30Hz and 50Hz respectively. The method for measuring the amplitude of the 189 
various sub-components is described in Figure 1. The PhNRON (PhNR for brief flash 190 
ERG) and PhNROFF amplitudes were measured from the pre-stimulus baseline and 191 
voltage at stimulus offset respectively to a fixed time point in their respective troughs. 192 
When determining the most appropriate fixed time point at which to measure the 193 
PhNRON and PhNROFF responses, the group averaged ERG of ADOA participants 194 
was subtracted from the group averaged ERG of the controls to obtain a difference 195 
ERG. The implicit time of the greatest discrepancy between the two was identified for 196 
the PhNRON and PhNROFF responses and was used as the fixed time point for all 197 
measurements. The fixed times at which the PhNR amplitudes were measured were 198 
as follows: focal PhNRON at 95 msec after onset, focal PhNROFF at 97 msec after 199 
offset, full-field PhNRON at 83 msec after onset, full-field PhNROFF at 102 msec after 200 
offset and full-field brief PhNR at 72 msec after onset. The identification of all peaks 201 
and troughs was determined objectively using Microsoft Excel i.e. as the 202 
minimum/maximum voltage within a fixed time window.  203 
 204 
Statistical Analysis 205 
Data expressed on a logarithmic scale (i.e. visual acuity, contrast sensitivity and 206 
visual field mean deviation) were converted (anti-logged) into a linear scale to 207 
calculate mean and standard deviation (SD) values. The mean and SD values were 208 
then converted back to log units. The distribution of the ERG data was checked for 209 
normality using the Shapiro-Wilk test. Where data were normally distributed, 210 
independent samples t-tests (2-tailed) were used to compare controls and 211 
participants with ADOA; the Mann-Whitney U test was used where data were non-212 
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normally distributed. In order to minimize Type 1 errors due to the number of 213 
comparisons made (n = 35), we applied a Bonferroni adjustment to the alpha level 214 
(0.05) and report observations as significant when p < 0.0014. Receiver Operating 215 
Characteristic (ROC) curve analysis was used to calculate the area under the curve 216 
(AUC) to assess the diagnostic potential of the various ERG components. The 217 
comparison between AUCs were made using the method described by Hanley and 218 
McNeil (1983)36. 219 
 220 
 221 
Results 222 
The clinical characteristics of all 12 ADOA participants from 6 families are shown in 223 
Table 1. The means and standard deviation for visual acuity, contrast sensitivity and 224 
mean deviation were 1.10 + 1.07 logMAR, 1.30 + 1.26 log units and -7.39 + 7.09 dB 225 
respectively. The visual field defects were mostly central or centrocecal and color 226 
vision defects were variable but participants from the same family had similar 227 
defects. More details regarding the relationship between the clinical characteristics 228 
and ERG data in ADOA participants is to be the subject of a future manuscript. 229 
 230 
Pattern ERGs 231 
PERGs recorded from 9 ADOA participants are shown superimposed on the group 232 
averaged trace of 16 controls in the left hand column of Figure 2A. It shows that the 233 
negative N95 component is reduced in amplitude for all participants with ADOA, 234 
beyond the 95% confidence intervals for the control data. The P50 amplitudes in 235 
ADOA participants were also below the lower 95% confidence intervals except for 236 
one participant. The middle column of Figure 2A and the data in Table 2 237 
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demonstrate that the mean P50 and N95 amplitudes were significantly reduced in 238 
ADOA participants compared to controls. The mean N95:P50 ratio in ADOA 239 
participants of 1.05 was significantly reduced compared to 1.73 in controls (Table 2). 240 
Although there was evidence of P50 and N95 loss in people with ADOA, the 241 
difference plot in the right hand column of Figure 2A is dominated by a negative 242 
going signal corresponding to the loss of the N95 component. 243 
 244 
Focal Long Duration Cone ERGs 245 
Focal long duration cone ERGs recorded from 12 participants with ADOA are shown 246 
superimposed on the group averaged trace of 16 controls in the left column of Figure 247 
2B. The typical ERG responses were characterized by the a-wave, b-wave, PhNRON, 248 
d-wave and PhNROFF. The PhNRON was reduced in amplitude below the lower 95% 249 
confidence limit of the control data in almost all ADOA participants except one. 250 
Notably, the waveform after stimulus offset varied considerably between ADOA 251 
participants. For instance in participants with ADOA, the most prominent positive 252 
peak after stimulus offset, assumed to be the d-wave, was delayed and had a broad 253 
peak whose maximum amplitude occurred at highly variable times (Figure 2B, right 254 
and middle columns). In comparison, this prominent peak was highly consistent 255 
between control participants with respect to implicit time and was reflected in the 256 
much smaller standard deviation of the d-wave implicit time in controls than in 257 
participants with ADOA (Table 2).  258 
 259 
The difference plot (Figure 2B, right) was dominated by two negative going waves 260 
representing the PhNRON and PhNROFF components affected by ADOA. The 261 
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difference plots of the ON and OFF components had similar profiles and amplitudes 262 
2.80 µV and 2.88 µV respectively. 263 
 264 
Long Duration Full-field Cone ERG 265 
The long duration full-field cone ERGs in Figure 2C were recorded from the same 266 
ADOA participants (thin lines) and controls (group averaged thick black line) as the 267 
focal cone ERGs in Figure 2B. The form of the long duration ERG was similar under 268 
focal and full-field conditions with one exception. There were two positive peaks 269 
immediately after light offset in the full-field ERG; the first being the d-wave24, 37. The 270 
mean amplitude of the PhNROFF, but not the PhNRON, was significantly reduced in 271 
participants with ADOA (Table 2). On the difference plot (Figure 2C, right) the 272 
amplitude of the PhNROFF difference (8.76 µV) was more than twice the amplitude of 273 
the PhNRON difference (3.42 µV) when measured. 274 
 275 
Once again, the OFF components showed greater variability than ON components 276 
for participants with ADOA. In fact, in at least 6 participants with ADOA, there was a 277 
third positive peak (3PP) after light offset not seen in controls (Figure 2C, left). There 278 
was no obvious pattern to the presence or absence of the 3PP in ADOA participants. 279 
The amplitude and implicit time of the 3PP measured from the ADOA group 280 
averaged trace was 13.34 µV and 75 msec after light offset respectively. 281 
Comparatively, none of the control traces displayed the 3PP prominently, although 282 
on close visual inspection, a kink corresponding in time with the 3PP was observed 283 
in some individual control traces. 284 
 285 
Comparison of Focal and Full-field Long Duration ERGs 286 
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The waveform of the focal and full-field long duration ERGs was further compared by 287 
normalizing the group averaged ERGs to their respective b-wave amplitudes (Figure 288 
3). The focal and full-field ERGs of controls (Figure 3A) and participants with ADOA 289 
(Figure 3B) had similar profiles although implicit times of the b-wave, PhNRON and d-290 
wave were significantly delayed in the focal ERG (p <0.01, data not shown). The 291 
most prominent positive peak of the focal ERG after light offset coincided with the 292 
2PP of the full-field ERG in the control traces while in the ADOA group, the broad 293 
peak of the focal ERG after offset described a curve that roughly matched the profile 294 
of the 2PP and 3PP of the full-field ERG. 295 
 296 
In controls, the PhNRs are proportionally greater in the focal ERG than in the full-297 
field ERG (Figure 3A). The losses in amplitudes of the PhNRs were also greater in 298 
the focal ERG than the full-field ERG in participants with ADOA (Figure 3B and 3C).  299 
 300 
The Brief Full-field ERG 301 
Brief full-field ERG recorded from 7 ADOA participants are shown in Figure 2D. 302 
Typical ERG responses had a-wave, b-wave, i-wave and PhNR components. The 303 
PhNR amplitude was reduced significantly in people with ADOA compared to 304 
controls (Figure 2D and Table 2). The difference plot in the right hand column of 305 
Figure 2D indicates that the greatest deficit in ADOA corresponds to the timing of the 306 
b-wave and the PhNR. An i-wave was recorded for all participants (controls and 307 
ADOA). Although it appeared more prominent in ADOA participants, there was no 308 
statistical difference in amplitude or implicit time between control and ADOA 309 
participants (Table 2).  310 
 311 
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Specificity and Sensitivity of the Different ERGs 312 
Receiver operating characteristics (ROC) curves were used to determine the 313 
effectiveness of the N95 and long duration focal and full-field PhNRs at 314 
discriminating participants with ADOA from controls for 9 participants with ADOA and 315 
16 controls for whom PERG and long duration focal and full-field ERG data were 316 
available (Figure 4). The AUC, sensitivity, specificity and cut off value which 317 
produced an optimal sensitivity while maintaining minimum specificity of ~90% are 318 
shown in Table 3. The N95 amplitude had the greatest diagnostic power. However, a 319 
comparison of the AUCs of the focal and full field PhNRs with the N95 amplitude, 320 
using the method described by Hanley and McNeil (1983)36 showed that the N95 321 
amplitude was only significantly more sensitive than the full-field PhNRON amplitude 322 
(z = 2.12). Therefore, considered in terms of their diagnostic ability, the focal PhNRs 323 
and N95 component were not significantly different.  324 
 325 
 326 
Discussion 327 
Effect of ADOA on ON and OFF Retinal Ganglion Cells 328 
In this study we sought to determine whether the PhNRON was preferentially affected 329 
in ADOA as might be predicted based on the study by William et al19.  Our findings 330 
however showed that in human patients, the PhNRON and PhNROFF amplitudes were 331 
equally reduced in the focal ERG, while in the full-field ERG, there was a greater 332 
reduction in the PhNROFF amplitude than the PhNRON amplitude. What then might 333 
explain this apparent contradiction? 334 
 335 
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In the study by William et al (2010), evidence for the preferential loss of ON-RGCs 336 
was based on mouse retinal flat mounts showing significant dendritic pruning of ON- 337 
but not OFF-RGCs. The experiment reported here however assessed the effect of 338 
ADOA on the ON- and OFF-RGCs by evaluating the PhNR amplitude of the human 339 
ERG, a functional measure. The role of the RGCs as primary originators of the 340 
PhNR has been demonstrated by Frishman and colleagues24-27, 34. In experiments 341 
using long duration full-field ERGs, they showed that that PhNRON and PhNROFF 342 
components were both reduced or eliminated after experimental glaucoma and 343 
intravitreal injection of tetrodotoxin (TTX) (an agent that blocks generation of sodium 344 
dependent spikes in retinal neurons) in macaque, as well as in patients with 345 
glaucoma. Although, the origins of the PhNRON and PhNROFF have not been 346 
conclusively traced to the ON- and OFF-RGCs respectively, Luo and Frishman34 347 
showed that the PhNRON (and b-wave) component but not the PhNROFF (or d-wave) 348 
was eliminated after injecting 2-amino-4-phosphonobutyric acid (APB) into the 349 
macaque retina to block synaptic transmission from photoreceptors to ON-bipolar 350 
cells and hence ON-RGCs. Injecting TTX after APB then removed the PhNROFF but 351 
not the d-wave thereby linking the PhNRON and PhNROFF components (although 352 
indirectly) to the ON and OFF pathways respectively.  353 
 354 
Previous human31, 38, 39 and animal24, 30 studies (including our mouse model) have 355 
shown that the PhNR amplitude is very susceptible to RGC damage with severe 356 
attenuation of PhNR amplitude recorded even when morphologic and other 357 
functional parameters were within normal range i.e. in early stage disease. It is 358 
possible that the PhNRON pathways may be selectively compromised at an earlier 359 
stage of the disease process than that studied here. A similar study in pre-360 
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symptomatic people with the OPA1 mutations or in people with ADOA at a much 361 
earlier stage of the disease (e.g. children with ADOA) could provide additional 362 
insights. 363 
 364 
Our findings may also be a reflection of the heterogeneous nature of ADOA. There 365 
are over 200 OPA1 mutations15, 16 which cause ADOA with wide phenotypic 366 
variations both within and between affected families 2, 40. Genotype-phenotype 367 
correlations have been difficult to establish in previous studies 3, 41 and the number of 368 
patients in each family of OPA1 mutations (except Family E) was insufficient to 369 
reliably explore such correlations. In the mouse model, the mutant mice (>10 months 370 
old) were genetically homogenous and disease severity correlated with age. 371 
Participants studied here were from 6 families, with a different mutation in each 372 
family (Table 1), and at different stages of the disease. This may have diluted 373 
observations that would have been made from a homogenous cohort. 374 
 375 
Comparison of Focal and Full-field PhNRs  376 
The long duration focal and full-field ERGs in this study were recorded using the 377 
same stimulus parameters, which were comparable to the parameters recommended 378 
by Kondo et al42 for eliciting focal responses. Although the waveforms of the focal 379 
and full field ERGs were similar, they were not identical (Figure 3A-B). There was a 380 
greater contribution of PhNRON and PhNROFF components to the focal ERG than to 381 
the full-field ERG (Figure 3A) which reflects the decreasing proportion of RGCs to 382 
other retinal cells with eccentricity43. The focal PhNRs were more severely affected 383 
than their full-field counterparts by ADOA and this was reflected in the larger AUCs 384 
found for the focal signals. These findings were consistent with the central field 385 
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defects recorded in ADOA participants in this study and in others2, 6, 44. In addition, 386 
whereas the focal PhNRs were both significantly reduced (p<0.001), only the full-387 
field PhNROFF was significantly reduced in the full-field ERG (Table 2). Although the 388 
N95 and focal PhNR amplitudes were highly discriminatory for ADOA, it should be 389 
noted that the participants in this study had relatively late stage disease. 390 
 391 
The symmetrical loss in the focal PhNRON and PhNROFF amplitudes (Figure 2B right 392 
column and Figure 3C) may reflect the 1:1 ratio of ON- to OFF-RGCs in the macula, 393 
while the greater loss in the full-field PhNROFF amplitude than the PhNRON amplitude 394 
(Figure 2C right column and Figure 3C) may reflect the nearly 1:2 ratio of ON- to 395 
OFF-RGCs in the peripheral retina 45-47. The broadening of the d-wave peak in the 396 
focal ERG and the presence of the 3PP in the full-field long ERG in participants with 397 
ADOA may be due to contributions from the cone receptor potential (CRP) and/or 398 
depolarizing OFF-bipolar cell responses after light offset which were unmasked in 399 
the relative absence of the negative going PhNROFF 48-50. The 2PP may be the iOFF-400 
wave described by Horn et al (2011)51, although in contrast to their results, this study 401 
did not record a significant difference in amplitude between controls and participants 402 
with ADOA. 403 
 404 
Comparison to other Electrophysiological Studies in ADOA 405 
Miyata et al29 reported a significant reduction in the full-field brief PhNR, but none in 406 
the a- or b-wave amplitude, in ADOA patients using white-on-white stimulus. Similar 407 
results were obtained by Barnard et al30 in the mouse model. In this present study, 408 
we show similar results using a red on blue stimulus. The flash luminance used in 409 
this study was adopted from a previous study in this laboratory52 and was 410 
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comparable to the flash luminance used by Miyata et al29. This supports findings that 411 
the red-on blue stimulus is effective for clinical evaluation of RGC function.   412 
 413 
Holder et al33 reported a significant reduction in N95 amplitude and the N95:P50 ratio 414 
of the PERG participants with ADOA. We obtained similar results and showed that 415 
the focal PhNRs and N95 amplitude were equally effective at discriminating controls 416 
from participants with ADOA. The focal ERG could therefore be used as an 417 
alternative to the PERG.  418 
 419 
In this study, as well as in that of Holder et al33, the P50 amplitude was significantly 420 
reduced. This may indicate that bipolar cell function is compromised in ADOA as has 421 
been put forward by Reis et al53. However, a reduction in P50 amplitude is also seen 422 
when only RGCs are compromised34, therefore the P50 reduction observed in this 423 
study could be due to dysfunction of bipolar cells, RGCs or both.  424 
 425 
Conclusion 426 
This study showed there was a nearly symmetrical reduction in the PhNRON and 427 
PhNROFF amplitudes in participants with ADOA with no evidence of a preferential 428 
ON-pathway loss. This suggests that ON- and OFF-RGCs may be equally affected in 429 
patients. In addition, in terms of their diagnostic potential, the focal PhNR-ON and -430 
OFF amplitudes were better than their full-field counterparts and were not 431 
significantly different from the N95 amplitude of the PERG. 432 
 433 
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FIGURES AND TABLES 583 
 584 
 585 
Table 1. Clinical Characteristics of Participants with ADOA 586 
NA – Not available 587 
Participant 
ID/Gender 
Family Age 
Visual 
Acuity, 
logMAR 
Contrast 
Sensitivity, 
log units 
Mean 
Deviation, dB 
Color 
Vision 
OPA1 
Mutation 
RE LE RE LE RE LE 
1010/F A 49 1.34 1.32 0.35 0.40 -27.03 -25.15 Mixed c.1202G>A 
1011/F B 55 1.64 1.62 0.00 0.00 -17.65 -19.58 Mixed C1508A 
1012/F C 58 0.80 1.00 1.15 1.05 -8.68 -10.39 Mixed IVS8+5G>A 
1013/F C 61 1.10 0.64 NA NA -12.47 -9.06 Mixed IVS8+5G>A 
1014/M D 33 1.40 1.32 0.30 0.45 -13.84 -11.89 
Protan/
Deutan NA 
1015/F D 31 1.02 0.98 1.05 1.05 -13.98 -13.20 
Protan/
Deutan NA 
1016/F E 18 0.80 0.80 1.65 1.35 -7.08 -8.15 Tritan IVS9+3A>T 
1017/F E 27 0.82 0.80 1.65 1.65 -5.14 -5.82 Tritan IVS9+3A>T 
1018/F E 59 0.86 0.96 0.90 0.75 -9.55 -7.03 Tritan IVS9+3A>T 
1019/F E 49 0.72 1.20 1.50 1.50 -5.99 -6.79 Tritan IVS9+3A>T 
1020/M E 46 0.98 1.20 1.65 1.20 -10.15 -8.21 Tritan IVS9+3A>T 
1021/M F 39 0.02 0.00 1.65 1.65 -1.31 -2.25 NA c.357delT 
Figure 1. Representative ERG traces of the (A) PERG, (B) full-field long-duration ERG and (C) full-
field brief flash ERG showing their components and how their amplitudes were measured (double 
headed arrows). The amplitudes of the P50, N95 (A), a-wave (a) and b-wave (b) (B-C) were 
measured as recommended by the International Society of Clinical Electrophysiology of Vision 
(ISCEV)1. The d-wave (d) amplitude was measured from the point of light offset to the peak of the d-
wave. The PhNRON (PhNR in brief flash) and PhNROFF amplitudes were measured from the pre-
stimulus baseline and voltage at stimulus offset respectively to a fixed time point in their respective 
troughs (see main text for details). The focal long duration ERG had the same profile as the full-field 
long duration except that in the focal ERG there was only one prominent positive peak after light 
offset, the d-wave.  
 24 Accepted 21-10-2015 
 
 588 
  589 
Figure 2. ERG traces of the (A) PERG, (B) focal long duration ERG, (C) full-field long duration ERG and (D) 
full-field brief flash ERG recorded from participants in this study. Left column: individual traces of 
participants with ADOA (thin lines) superimposed on the group averaged ERG of 16 controls (thick lines) for 
each type of ERG recorded. The number of participants with ADOA in A, B, C and D are 9, 12, 12 and 7 
respectively. Dotted lines represent 95% confidence intervals. Middle column: comparison between group-
averaged traces of controls (thick black line) and ADOA participants (thick red line). Right column: 
difference plots generated by subtracting the group-averaged ADOA ERG from the control ERG. 
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Table 2. Means of Amplitudes and Implicit Times in Controls and Participants with ADOA 590 
ERG TYPE Component 
ADOA Mean 
Values 
Control Mean 
Values 
P-value 
PERG P50 A, µV 1.92 + 0.81 3.18 + 0.81 0.0011* 
T, msec 49.03 + 3.67 53.16 + 3.28 0.0082 
N95 A, µV 2.12 + 1.31 5.20 + 0.87 0.0000* 
T, msec 101.67  + 11.21 99.77 + 7.76 0.6212† 
N95:P50 Ratio 1.05 + 0.31 1.73 + 0.47 0.0009*† 
      
Focal ERG a-wave A, µV 1.76 + 0.94 2.22 + 0.61 0.1301 
T, msec 23.00 + 1.72 23.75 + 1.74 0.2534 
b-wave A, µV 5.29 + 2.08 6.76 + 1.74 0.0524 
T, msec 46.25 + 3.14 49.81 + 4.88 0.0271 
PhNRON A, µV 1.02 + 0.97 3.81 + 1.74 0.0000* 
T, msec 109.25 + 7.16 104.50 + 8.49 0.1299 
d-wave A, µV 2.81 + 1.52 3.12 + 1.04 0.5290 
T, msec 321.92 + 13.80 302.41 + 5.92 0.0004* 
PhNROFF A, µV -1.97 + 1.52 0.93 + 1.23 0.0000* 
T, msec 138.08 + 9.94 113.09 + 14.64 0.0000*† 
       
Full-field 
Long ERG 
a-wave A, µV 15.87 + 4.44 18.84 + 4.45 0.0917 
T, msec 22.50 + 1.09 23.16 + 1.70 0.2537 
b-wave A, µV 33.57 + 10.67 41.29 + 11.18 0.0768 
T, msec 41.83 + 2.86 42.16 + 2.47 0.7515 
PhNRON A, µV 12.26 + 3.95 15.68 + 4.36 0.0430 
T, msec 96.18 + 9.16 92.72 + 4.15 0.2471 
d-wave A, µV 15.11 + 6.20 12.84 + 4.89 0.2866 
T, msec 274.67 + 1.15 273.47 + 1.02 0.0075† 
2nd positive 
peak 
A, µV 15.48 + 4.87 16.10 + 7.55 0.8064 
T, msec 302.50 + 8.35 298.19 + 2.00 0.1054† 
PhNROFF A, µV -8.31 + 5.69 0.45 + 5.74 0.0005* 
T, msec 178.33 + 27.02 132.19 + 17.30 0.0000*† 
      
Full-field 
Brief ERG 
a-wave A, µV 20.60 + 3.79 25.73 + 5.91 0.0480† 
T, msec 17.50 + 0.69 17.22 + 0.76 0.4133 
b-wave A, µV 59.75 + 14.58 77.88 + 18.17 0.0302 
T, msec 35.39 + 1.51 35.38 + 1.26 0.9767 
i-wave A, µV 14.00 + 8.37 16.19 + 7.58 0.5420 
T, msec 58.04 + 2.04 57.61 + 2.37 0.6844 
PhNR A, µV 12.93  + 3.38 22.39 + 6.17 0.0011* 
T, msec 72.75 + 4.13 70.59 + 6.40 0.4244† 
Data are expressed as mean + standard deviation.  591 
A – Amplitude; T – Implicit time from stimulus onset 592 
* – Value is significant at p < 0.0014 level; † – data was non-uniformly distributed and Mann-Whitney 593 
U test was used for statistical comparison. 594 
  595 
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 596 
 597 
Figure 3. A comparison of the long duration focal (dashed lines) and full field (solid lines) group-598 
averaged ERGs for (A) controls, (B) participants with ADOA and (C) difference plots. ERGs have 599 
been normalised to the b-wave amplitude of their respective control group-averaged ERG. 600 
 601 
 602 
 603 
 604 
Table 3. Sensitivity, Specificity and Area Under Curve of ROC Analysis for ERG Components 605 
Test Variable Area (95% CI) Sensitivity Specificity Cut Off Value 
N95 0.99 (0.97 – 1.00) 93.80 100.00 4.12 µV 
N95:P50 0.92 (0.81 – 1.00) 81.30 89.90 1.44 
Focal PhNRON 0.92 (0.81 – 1. 00) 81.30 100.00 2.62 µV 
Focal PhNROFF 0.95 (0.87 – 1.00) 81.30 100.00 0.24 µV 
Full-field PhNRON 0.78 (0.60 – 0.97) 50.00 100.00 16.99 µV 
Full-field PhNROFF 0.83 (0.73 – 0.99) 62.50 89.90 0.35 µV 
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Figure 4. Receiver Operating Characteristic (ROC) curves derived using (A) N95 component and 
N95:P50 ratio of the PERG, (B) focal PhNRON and PhNROFF amplitudes and (C) full-field PhNRON and 
PhNROFF amplitudes. Diagonal dashed line is the reference line. 
